Phosphagenics CEO steps down
Dr Esra Ogru, CEO of Phosphagenics (ASX: POH), handed in her resignation as a director of the company effective as of last Thursday 18 July 2013.
The Phosphagenics board suspended Esra Ogru on 1 July, after it discovered apparent irregular transactions in the company’s invoicing and accounting records.
The company expects to announce the key findings of an independent investigation on Wednesday 24 July 2013.
Phosphagenics’ shares were trading at $0.105 at about 3 pm on Monday.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
